Integrating Untargeted and Quantitative Metabolomics Workflows
The pharmaceutical and biotechnology industries face a persistent challenge in metabolomics research: translating exploratory discoveries into validated, quantifiable biomarkers suitable for clinical development. Traditional approaches force researchers to choose...
Metabolic Signatures of Alzheimer’s Disease
Beyond Plaques and Tangles: How Untargeted Metabolomics Detects Distinct Signatures in Alzheimer’s Disease Untargeted metabolomics captures systemic metabolic changes in neurodegenerative diseases, such as Alzheimer’s, identifying altered pathways and...
Untargeted Metabolomics for Dietary Intervention Insights
Dietary intervention studies have historically relied on a limited panel of predefined endpoints: glucose and lipid profiles, inflammatory markers, anthropometric measurements, and questionnaire-based assessments. While these traditional biomarkers provide valuable...